Altomare G et al. |
Treatment of bullous pemphigoid with erythromycin: a reappraisal. |
1999 Oct-Nov |
Eur J Dermatol |
pmid:10610238
|
Czeizel AE et al. |
A population-based case-control teratologic study of oral erythromycin treatment during pregnancy. |
1999 Nov-Dec |
Reprod. Toxicol. |
pmid:10613401
|
Urmösi J |
[Thrombophlebitis of the sinus cavernosus]. |
1975 |
Stomatol DDR |
pmid:1061410
|
|
National guideline for the management of Chlamydia trachomatis genital tract infection. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases). |
1999 |
Sex Transm Infect |
pmid:10616372
|
|
National guideline for the management of non-gonococcal urethritis. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases) |
1999 |
Sex Transm Infect |
pmid:10616373
|
|
National guideline for the management of early syphilis. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases). |
1999 |
Sex Transm Infect |
pmid:10616379
|
|
National guideline for the management of lymphogranuloma venereum. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases). |
1999 |
Sex Transm Infect |
pmid:10616382
|
|
National guideline for the management of chancroid. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases). |
1999 |
Sex Transm Infect |
pmid:10616383
|
Chieppa DM et al. |
Effects of erythromycin on human colonic circular muscle in idiopathic chronic constipation. |
2000 |
Eur. J. Clin. Invest. |
pmid:10620004
|
Novikova SI et al. |
Introduction of a mini-gene encoding a five-amino acid peptide confers erythromycin resistance on Bacillus subtilis and provides temporary erythromycin protection in Proteus mirabilis. |
2000 |
FEMS Microbiol. Lett. |
pmid:10620668
|
Desaki M et al. |
Erythromycin suppresses nuclear factor-kappaB and activator protein-1 activation in human bronchial epithelial cells. |
2000 |
Biochem. Biophys. Res. Commun. |
pmid:10623585
|
Kdesh A et al. |
Effect of erythromycin on myocardial repolarization in patients with community-acquired pneumonia. |
1999 |
South. Med. J. |
pmid:10624910
|
Gallardo MA and Thomas I |
Hypersensitivity reaction to erythromycin. |
1999 |
Cutis |
pmid:10626100
|
Lagrou K et al. |
Macrolide resistance in Belgian Streptococcus pneumoniae. |
2000 |
J. Antimicrob. Chemother. |
pmid:10629023
|
GarcÃa Sánchez MJ et al. |
[Bacterial resistances]. |
1999 |
Aten Primaria |
pmid:10630037
|
Sullivan S et al. |
Stevens-Johnson syndrome secondary to erythromycin. |
1999 |
Ann Pharmacother |
pmid:10630839
|
Trinkle R |
Comment: evaluation of the clinical and financial impact of intravenous erythromycin therapy in hospitalized patients. |
1999 |
Ann Pharmacother |
pmid:10630842
|
Puri SK and Singh N |
Azithromycin: antimalarial profile against blood- and sporozoite-induced infections in mice and monkeys. |
2000 |
Exp. Parasitol. |
pmid:10631075
|
Weston WL and Morelli JG |
Steroid rosacea in prepubertal children. |
2000 |
Arch Pediatr Adolesc Med |
pmid:10632252
|
|
Hypertrophic pyloric stenosis in infants following pertussis prophylaxis with erythromycin--Knoxville, Tennessee, 1999. |
1999 |
MMWR Morb. Mortal. Wkly. Rep. |
pmid:10634345
|